Published Jul 30, 2026, 8:32 AM ET · Updated 3 months ago · 1 source

Braveheart Bio targets $1.2 billion valuation in US IPO

reuters

·

Original Report

Braveheart Bio targets $1.2 billion valuation in US IPO